Clinical trial for Lymphatic Reconstruction
Official title Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study
ClinicalTrials.gov ID: NCT06887205
What this study is testing
- What it's testing
- The study aims to see if performing lymphatic reconstruction at the time of lymph node removal helps stop lymphedema.
- Who it's for
- Melanoma patients who are having lymph node removal surgery.
- What's involved
- Participants will have lymphatic reconstruction done during their surgery and will be followed with visits and tests.
- Time commitment
- The study lasts until follow‑up visits after surgery, with several check‑ins over months.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participants greater than or equal to 18 years of age.
- Participants willing to participate.
- Participants able to complete informed consent.
- Participants with a diagnosis of Melanoma undergoing ALND or ILND.
You likely can't join if
- Participant staking anticoagulants within 7 days prior to surgery.
- Participants that are known to be pregnant at the time of surgery.
- Participants with BMI greater than 50.0
The study team makes the final eligibility decision.
Where it is enrolling
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Houston, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.